MiMedx Group (MDXG) Tops Q3 EPS by 1c

MiMedx Group (NASDAQ: MDXG) reported Q3 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $49 million versus the consensus estimate of $48.61 million.

MiMedx Group sees Q415 revenue of $49.5-52.5 million, versus the consensus of $51.7 million.

MiMedx Group sees FY2015 revenue of $185-188 million, versus the consensus of $187.1 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c
• BeyondSpring Inc. (BYSI) Reports Q2 Loss of $0.02